MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-25-0007365
Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere Private Limited - pharma in Navsari, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹6.85 Cr
▲ 82% YoY
Net loss · FY 2023
₹2.36 Cr
Net margin -34.5%
EBITDA · FY 2023
-₹72.23 Lakh
EBITDA margin -10.5%
Authorised capital
₹1.3 Cr
Registered with MCA
Paid-up capital
₹1.19 Cr
Issued & subscribed
Open charges
₹7.8 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Employees · EPFO
48
Provident fund records
About Daiwik Pharmasphere Private Limited
Data last updated:
Daiwik Pharmasphere Private Limited is a private limited company based in Navsari, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC063325. Its GSTIN is 24AADCD6955D1ZS (Gujarat).
The company has an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.19 Cr. It is led by directors including Sanjay Anupchand Mehta and Rajesh Gunvantrai Bhayani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17 Abvp Shopping Centre Opp – Parsi Hospital, Navsari, Gujarat, India – 396445.
As per the financials filed for FY 2023, the company reported a revenue of ₹6.85 Cr, a growth of 82% compared to the previous year. For the same year it recorded a net loss of ₹2.36 Cr (net margin -34.5%) and EBITDA of -₹72.23 Lakh (EBITDA margin -10.5%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 122% over five years.
The company has about 48 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.8 Cr on record.
Daiwik Pharmasphere Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-25-0007365). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Daiwik Pharmasphere Private Limited
CIN U24230GJ2010PTC063325
Registration Number 063325
Incorporation Date 22 December 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-25-0007365
Key People
Sanjay Anupchand Mehta Director Rajesh Gunvantrai Bhayani Director Neha Bharat Desai Director Recognitions & Rankings of Daiwik Pharmasphere
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address17 Abvp Shopping Centre Opp – Parsi Hospital, Navsari, Gujarat, India – 396445
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Daiwik Pharmasphere Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Daiwik Pharmasphere Private Limited
The main business activity of Daiwik Pharmasphere is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Daiwik Pharmasphere Private Limited FY 2025 filings available
Daiwik Pharmasphere Private Limited reported revenue of ₹6.85 Cr (up 82% YoY) for FY 2023.
Revenue · FY 2023
₹6.85 Cr ▲ 82%
Net loss · FY 2023
₹2.36 Cr margin -34.5%
EBITDA · FY 2023
-₹72.23 Lakh margin -10.5%
Compounded Annual Growth Rate (CAGR) of Daiwik Pharmasphere Private Limited
Revenue CAGR growth
1 year
▲ 82%
3 years · compounded
▲ 35%
5 years · compounded
▲ 122%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 17%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 122% over five years, including 82% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Daiwik Pharmasphere Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹6.85 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹72.23 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.36 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Daiwik Pharmasphere Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -34.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Daiwik Pharmasphere are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere has 8 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Anupchand Mehta | Director | 28 Jun 2017 | 9 Years 3 Months | Current |
| Rajesh Gunvantrai Bhayani | Director | 22 Dec 2010 | 15 Years 9 Months | Current |
| Neha Bharat Desai Also directs: Aditya Polynet Private Limited | Director | 11 Jul 2019 | 7 Years 3 Months | Current |
| Apurva Gunvantrai Bhayani | Director | 28 Jun 2017 | 9 Years 3 Months | Current |
| Ajay Jayantilal Patel Also directs: B Tex Ointment Manufacturing Company Private Limited | Director | 22 Dec 2010 | 15 Years 9 Months | Current |
| Atit Bhulabhai Patel | Director | 25 Feb 2015 | 11 Years 7 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer Comparison of Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Megha Healthcare Private Limited | ₹6.88 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Quality Nexgen Pharmaceuticals Private Limited | ₹6.88 Cr (FY 2022) | •••• | •••• | -42.0% | •••• | Mumbai, Maharashtra, India |
| Ikem Pharma Private Limited | ₹6.87 Cr (FY 2024) | •••• | •••• | -62.0% | •••• | Hyderabad, Telangana, India |
| Good Kare Medico Private Limited | ₹6.86 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Saksham Pharmaceuticals (India) Limited | ₹6.86 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | New Delhi, Delhi, India |
| Daiwik Pharmasphere Private Limited this company | ₹6.85 Cr (FY 2023) | •••• | •••• | 82.0% | •••• | Navsari, Gujarat, India |
| Colinz Laboratories Ltd Listed | ₹6.83 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Mumbai, Maharashtra, India |
| Beid Healthcare Private Limited | ₹6.81 Cr (FY 2024) | •••• | •••• | -77.0% | •••• | Navi Mumbai, Maharashtra, India |
| Estragen Pharma Private Limited | ₹6.8 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Jaipur, Rajasthan, India |
| Pharmachem Biotech (I) Private Limited | ₹6.79 Cr (FY 2025) | •••• | •••• | 72.0% | •••• | Mumbai, Maharashtra, India |
| Care Tech Life Science Private Limited | ₹6.78 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Daiwik Pharmasphere by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere Private Limited is audited by P. K. SHAH & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P. K. SHAH & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Daiwik Pharmasphere Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Daiwik Pharmasphere Private Limited
Open charges
₹7.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2016 | Hdfc Bank Limited | ₹3.9 Cr | Open |
| 18 Jun 2016 | Hdfc Bank Limited | ₹3.9 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere Private Limited has a workforce of 48 employees as of Apr 02, 2024.
Employee count
48
Active EPFO establishments
1
Employee growth
60%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere Private Limited has 11 board changes on record since 2010: 8 appointments and 3 cessations. The latest: Neha Bharat Desai ceased to be Additional Director on 30 Sep 2019.
AGM
Daiwik Pharmasphere Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Daiwik Pharmasphere Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 3.90 Cr registered on 18 Jun 2016 with Charge ID 100043178 was modified on 18 May 2022.
Charges
A charge with Hdfc Bank Limited of Rs. 3.90 Cr registered on 29 Jun 2016 with Charge ID 100037206 was modified on 27 Apr 2022.
Ceased
Neha Bharat Desai ceased to be Additional Director.
Appointed
Neha Bharat Desai was appointed as Director.
Appointed
Apurva Gunvantrai Bhayani was appointed as Director.
Appointed
Kalpesh Mahendra Mehta was appointed as Director.
Appointed
Sanjay Anupchand Mehta was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.90 Cr with Charge ID 100037206 was registered on 29 Jun 2016.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.90 Cr with Charge ID 100043178 was registered on 18 Jun 2016.
Ceased
Atit Bhulabhai Patel ceased to be Additional Director.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Daiwik Pharmasphere Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Daiwik Pharmasphere Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Daiwik Pharmasphere Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCD6955D1ZS | Gujarat | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Daiwik Pharmasphere Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daiwik Pharmasphere Private Limited
Daiwik Pharmasphere is an active private limited company based in Navsari, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 December 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC063325.
Daiwik Pharmasphere reported revenue of ₹6.85 Cr for FY 2023 (up 82% YoY).
Daiwik Pharmasphere has 8 current directors:
- Sanjay Anupchand Mehta - Director
- Rajesh Gunvantrai Bhayani - Director
- Neha Bharat Desai - Director
- Apurva Gunvantrai Bhayani - Director
- Ajay Jayantilal Patel - Director
- Atit Bhulabhai Patel - Director
- Kalpesh Mahendra Mehta - Director
- Tejas Shantilal Desai - Director
Daiwik Pharmasphere reported a net loss of ₹2.36 Cr (net margin -34.5%) and EBITDA of -₹72.23 Lakh (EBITDA margin -10.5%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Daiwik Pharmasphere is 35% over three years and 122% over five years. In the latest year (FY 2023) revenue rose 82%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Daiwik Pharmasphere is 24AADCD6955D1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Daiwik Pharmasphere is U24230GJ2010PTC063325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Daiwik Pharmasphere was incorporated on 22 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Daiwik Pharmasphere by revenue are Megha Healthcare Private Limited, Quality Nexgen Pharmaceuticals Private Limited, Ikem Pharma Private Limited, Good Kare Medico Private Limited, Saksham Pharmaceuticals (India) Limited and 5 more, all in the Pharma industry (Formulations).
Neha Bharat Desai ceased to be Additional Director on 30 Sep 2019. Neha Bharat Desai was appointed as Director on 11 Jul 2019. Apurva Gunvantrai Bhayani was appointed as Director on 28 Jun 2017. Daiwik Pharmasphere has 11 board changes on record in total.
Yes, Daiwik Pharmasphere is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-25-0007365).